DUBLIN, February 25, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/q4r37j/aortic_endografts) has announced the addition of the "Aortic Endografts Market: 2016 Edition" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The aortic intervention market has consolidated. During 2015, Medtronic bought Aptus Endosystems for $110 million, Lombard Medical bought Altura for $23 million and Endologix merged with TriVascular in a $211 million deal.
The only innovative company left standing independent in the space is Cardiatis, which is expected to be acquired during 2016 given its disruptive aortic flow diversion technology, its extensive patent portfolio, and the recent Veith symposium presentations highlighting its utility in repairing difficult to treat thoraco-abdominal aneurysms, .
The global aortic endografts market was estimated at $1.8 billion in 2015, a growth of 6% over its level in 2014. At $1.4 billion in revenue, the infra-renal segment of the market has matured but is expected to continue growing in the low-single digit range during the rest of the decade.
Aortic branch management strategies represent the next frontier in endovascular aortic aneurysm repair with the promise to expand applicability into the thoracoabdominal space and the aortic arch, an estimated $900 million in new market potential.
Fenestrated and branched endografts are being used in many centers and have increased the proportion of aortic aneurysms treated endovascularly. During the rest of the decade these devices will become perfected, simpler to use and stockable in off-the-shelf configurations.
The acceptance of the off-the-shelf aortic flow diversion technology that can bridge and preserve circulation in the celiac, superior mesenteric and the renals, is a game changer and promises to breathe new growth into the overall market.
This report offers senior executives in the medical technology industry a comprehensive overview of the market with a consensus forecast to 2020 supported by three event impacted scenarios.
The report, which has been tracking this highly guarded space since 2008, is the definitive guide to the current industry landscape.
Key Topics Covered:
1. Executive Summary
2. Aortic Aneurysms
2.1 Open Surgical Repair of Aortic Aneurysms
2.2 Endovascular Repair of Aortic Aneurysms
3. Aortic Endografts Market
3.1 Leading Companies & Their Devices
3.2 Recent Mergers & Acquisitions in the Space
3.3 Leading Companies Market Shares
3.4 Geographic Segmentation
4. Market Segmentation
4.1 Infra-Renal Aortic Endografts Market
4.2 Thoracic Aortic Endografts Market
4.3 Fenestrated & Branched Aortic Endografts
4.4 Aneurysm Sealing Endografts
4.5 Aortic Flow Diverting Endografts
5. Market Forecast
5.1 Endovascular Opportunity In Thoraco-Abdominal Aneurysm Repair
5.2 Endovascular Opportunity In Aortic Dissection Repair
5.3 Endovascular Opportunity In Ascending Aortic Arch Aneurysms
5.4 Future Scenarios
6. Companies In The Space
6.1 Bolton Medical
6.2 Braile Biomedica
6.4 Cook Medical
6.8 Gore Medical
6.10 Lifetech Scientific
6.11 Lombard Medical
6.13 Microport Medical
6.14 Nano Endoluminal
For more information visit http://www.researchandmarkets.com/research/q4r37j/aortic_endografts
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets